서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Author

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 23 of 23

Issue DateTitle / Author(s) / CitationFileAltmetrics
1998-09
Locoregional response and increased natural killer activity after intratumoral injection of HLA-B7/β2-microglobulin gene in patients with cancer
DOI
2005-09
High-dose versus low-dose cyclophosphamide in combination with G-CSF for peripheral blood progenitor cell mobilization
DOI
2007-11
Phase III trial of two versus four additional cycles in patients who are nonprogressive after two cycles of platinum-based chemotherapy in non small-cell lung cancer
link
2007-11
Phase III trial of two versus four additional cycles in patients who are nonprogressive after two cycles of platinum-based chemotherapy in non small-cell lung cancer
link
2015-08
Multinational randomized phase III trial with or without consolidation chemotherapy using docetaxel and cisplatin after concurrent chemoradiation in inoperable stage III non-small-cell lung cancer: KCSG-LU05-04
DOI
2016-02
Longitudinal monitoring of EGFR mutations in plasma predicts outcomes of NSCLC patients treated with EGFR TKIs: Korean Lung Cancer Consortium (KLCC-12-02)
DOI
2016-04
Tolerability and Outcomes of First-Line Pemetrexed-Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in Korean Patients with Advanced Nonsquamous Non-small Cell Lung Cancer: A Post Hoc Descriptive Subgroup Analysis of a Randomized, Phase 3 Trial
DOI
2016-04
A randomized, multicenter, phase II/III study to determine the optimal dose and to evaluate the efficacy and safety of pegteograstim (GCPGC) on chemotherapy-induced neutropenia compared to pegfilgrastim in breast cancer patients: KCSG PC10-09
DOI
2017-04
Feasibility and Efficacy of Eribulin Mesilate in Korean Patients with Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study Results
DOI
2018-08
Nivolumab in advanced non-small-cell lung cancer patients who failed prior platinum-based chemotherapy
DOI
2019-09
Safety, tolerability, and anti-tumor activity of olmutinib in non-small cell lung cancer with T790M mutation: A single arm, open label, phase 1/2 trial
DOI
2019-12
Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: Results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1-2 study
DOI
2020-10
Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea
DOI
2021-07
Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis

Gelmon, Karen A.; Fasching, Peter A.; Couch, Fergus J.; Balmaña, Judith; Delaloge, Suzette; Labidi-Galy, Intidhar; Bennett, James; McCutcheon, Susan; Walker, Graham; O'Shaughnessy, Joyce; Collaborating Investigator; Timcheva, Constanta; Tomova, Antoaneta; Eisen, Andrea; Lemieux, Julie; Bazan, Fernando; Bourgeois, Hugues; Chakiba, Camille; Chehimi, Mohamad; Dalenc, Florence; De La Motte Rouge, Thibault; Frenel, Jean-Sébastien; Gonçalves, Anthony; Hardy-Bessard, Anne Claire; Lamy, Regine; Levy, Christelle; Lortholary, Alain; Mailliez, Audrey; Medioni, Jacques; Patsouris, Anne; Spaeth, Dominique; Teixeira, Luis; Tennevet, Isabelle; Villanueva, Cristian; You, Benoit; Ettl, Johannes; Gerber, Bernd; Hoffmann, Oliver; Park-Simon, Tjoung-Won; Reinisch, Mattea; Tio, Joke; Wimberger, Pauline; Boer, Katalin; Ballestrero, Alberto; Bianchini, Giampaolo; Biganzoli, Laura; Bordonaro, Roberto; Cognetti, Francesco; De Laurentiis, Michelino; De Placido, Sabino; Guarneri, Valentina; Montemurro, Filippo; Naso, Giuseppe; Santoro, Armando; Zamagni, Claudio; Kim, Seung-Jin; Nakamura, Seigo; Chae, Yee Soo; Cho, Eun Kyung; Hyun, Kim Jee; Im, Seock-Ah; Lee, Keun Seok; Park, Yeon Hee; Sohn, Joo Hyuk; Byrski, Tomasz; Huzarski, Tomasz; Kukielka-Budny, Bozena; Nowecki, Zbigniew; Szoszkiewicz, Renata; Tarnawski, Rafal; Dvornichenko, Viktoria; Moiseenko, Fedor; Mukhametshina, Guzel; Poddubskaya, Elena; Popova, Ekaterina; Tarasova, Anna; Vats, Anna; Adamo, Bárbara; Conejero, Raquel Andrés; Torres, Antonio Antón; Gelpi, Judith Balmaña; Fernández, Nieves Díaz; González, Alejandro Falcón; Garcia, Juan; Lorenzo-Lorenzo, Isabel; Antón, Fernando Moreno; Santisteban, Marta; Stradella, Agostina; Huang, Chiun-Sheng; Aksoy, Sercan; Arslan, Cagatay; Artac, Mehmet; Aydiner, Adnan; Ozyilkan, Ozgur; Sezer, Emel; Armstrong, Anne; Barrett, Sophie; Borley, Annabel; Kemp, Zoe; Michie, Caroline; Mukesh, Mukesh; Perren, Timothy; Swampillai, Angela; Young, Tammy

European Journal of Cancer, Vol.152, pp.68-77

DOI
2022-04
A Phase 1/2 Study of Lazertinib 240 mg in Patients With Advanced EGFR T790M-Positive NSCLC After Previous EGFR Tyrosine Kinase Inhibitors
DOI
2022-07
Long-term follow-up results of cytarabine-containing chemotherapy for acute promyelocytic leukemia
DOI
2023-10
Amivantamab plus lazertinib in osimertinib-relapsed <i>EGFR</i>-mutant advanced non-small cell lung cancer: a phase 1 trial
DOI
2023-12
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY

Balmana, Judith; Fasching, Peter A.; Couch, Fergus J.; Delaloge, Suzette; Labidi-Galy, Intidhar; O'Shaughnessy, Joyce; Park, Yeon Hee; Eisen, Andrea F.; You, Benoit; Bourgeois, Hughes; Goncalves, Anthony; Kemp, Zoe; Swampillai, Angela; Jankowski, Tomasz; Sohn, Joo Hyuk; Poddubskaya, Elena; Mukhametshina, Guzel; Aksoy, Sercan; Timcheva, Constanta V.; Park-Simon, Tjoung-Won; Anton-Torres, Antonio; John, Ellie; Baria, Katherine; Gibson, Isabel; Gelmon, Karen A.; Koynova, Tatyana; Popov, Vasil; Timcheva, Constanta; Tomova, Antoaneta; Eisen, Andrea; Gelmon, Karen; Lemieux, Julie; Augereau, Paule; Bazan, Fernando; Becuwe, Celia; Bourgeois, Hugues; Chakiba, Camille; Chehimi, Mohamad; Cheneau, Caroline; Dalenc, Florence; de Guillebon, Eleonore; de la Motte Rouge, Thibault; Frenel, Jean-Sebastien; Goncalves, Anthony; Grenier, Julien; Hardy-Bessard, Anne Claire; Lamy, Regine; Levy, Christelle; Lortholary, Alain; Mailliez, Audrey; Medioni, Jacques; Patsouris, Anne; Spaeth, Dominique; Teixeira, Luis; Tennevet, Isabelle; Venat-Bouvet, Laurence; Villanueva, Cristian; You, Benoit; Ettl, Johannes; Fasching, Peter; Gerber, Bernd; Hanusch, Claus Alexander; Hoffmann, Oliver; Park-Simon, Tjoung-Won; Malter, Wolfram; Reinisch, Mattea; Tio, Joke; Wimberger, Pauline; Boer, Katalin; Dank, Magdolna; Ballestrero, Alberto; Bianchini, Giampaolo; Biganzoli, Laura; Bordonaro, Roberto; Cognetti, Francesco; Cortesi, Enrico; De Laurentiis, Michelino; De Placido, Sabino; Gianni, Luca; Guarneri, Valentina; Marchetti, Paulo; Montemurro, Filippo; Mosconi, Anna Maria; Naso, Giuseppe; Puglisi, Fabio; Santoro, Armando; Zamagni, Claudio; Iwata, Hiroji; Kim, Seung-Jin; Nakamura, Seigo; Chae, Yee Soo; Cho, Eun Kyung; Kim, Jee Hyun; Im, Seock-Ah; Lee, Keun Seok; Park, Yeon Hee; Sohn, Joo Hyuk; Byrski, Tomasz; Huzarski, Tomasz; Jankowski, Tomasz; Kukielka-Budny, Bozena; Lacko, Aleksandra; Nowecki, Zbigniew; Senkus-Konefka, Elzbieta; Szoszkiewicz, Renata; Tarnawski, Rafal; Andabekov, Timur; Dvorkin, Mikhail; Dvornichenko, Viktoria; Moiseenko, Fedor; Mukhametshina, Guzel; Poddubskaya, Elena; Popova, Ekaterina; Tarasova, Anna; Sakaeva, Dina; Shomova, Marina; Vats, Anna; Adamo, Barbara; Conejero, Raquel Andres; Torres, Antonio Anton; Gelpi, Judith Balmana; de Ibarguen, Blanca Cantos Sanchez; Jurado, Josefina Cruz; Fernandez, Nieves Diaz; Gonzalez, Alejandro Falcon; Garcia, Juan; Santiago, Santiago Gonzalez; Carrasco, Fernando Henao; Lorenzo, Isabel Lorenzo; Anton, Fernando Moreno; Garcia, Beatriz Rojas; Beltran, Salomon Menjon; Santisteban, Marta; Stradella, Agostina; Hou, Ming-Feng; Huang, Chiun-Sheng; Lin, Yung-Chang; Tseng, Ling-Ming; Wang, Hwei-Chung; Aksoy, Sercan; Arslan, Cagatay; Artac, Mehmet; Aydiner, Adnan; Disel, Umut; Ozkan, Metin; Ozyilkan, Ozgur; Sezer, Emel Yaman; Yetisyigit, Tarkan; Armstrong, Anne; Barrett, Sophie; Borley, Annabel; Kemp, Zoe; Michie, Caroline; Mukesh, Mukesh; Perren, Timothy; Swampillai, Angela; Chaudhry, Madhu; Young, Tammy

BREAST CANCER RESEARCH AND TREATMENT

DOI
2023-12
Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16)
DOI
2024-01
Lazertinib versus Gefitinib as First-Line Treatment for EGFR-mutated Locally Advanced or Metastatic NSCLC: LASER301 Korean Subset
DOI
2024-06
A randomized, multicenter, open-label, phase III trial comparing anthracyclines followed by taxane versus anthracyclines followed by taxane plus carboplatin as (neo) adjuvant therapy in patients with early triple-negative breast cancer: Korean Cancer Study Group BR 15-1 PEARLY trial.
DOI
2024-08
Genomic and transcriptomic profiles associated with response to eribulin and nivolumab combination in HER-2-negative metastatic breast cancer
DOI
2024-10
Updated overall survival and ctDNA analysis in patients with EGFR T790M-positive advanced non-small cell lung cancer treated with lazertinib in the phase 1/2 LASER201 study
DOI
1